Migfilin: Cell Adhesion Effect and Comorbidities.

Authors:
Duan B; Qin Z; Gu X; Li Y.

Journal:
Onco Targets Ther

Publication Year: 2022

DOI:
10.2147/OTT.S357355

PMCID:
PMC9034862

PMID:
35469339

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Onco Targets Ther

Abbreviation: Onco Targets Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Applications of Yttrium-90 (<sup>90</sup>Y) in Hepatocellular Carcinoma.
Jiang Z; Yang F; Wang W. (2024) - Transparency Score: 3/6
Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Functi…
Xie C; Hao X; Yuan H and 3 more (2024) - Transparency Score: 3/6
Prognostic Factors and Construction of Nomogram Prediction Model of Lung Cancer Patients Using Clin…
Zhang Y; Wan W; Shen R and 6 more (2024) - Transparency Score: 3/6
TSC22D2 Regulates ACOT8 to Delay the Malignant Progression of Colorectal Cancer.
Zhou N; Guo C; Du J and 4 more (2024) - Transparency Score: 3/6
Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Directi…
Buller DM; Antony M; Ristau BT. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors declare no competing interests in this work."

Evidence found in paper:

"This work was supported by the matching project Fund of Shanghai University of Medicine and Health Sciences (E4-6200-20-201001), the Seed Fund of Shanghai University of Medicine and Health Sciences (E3-0200-20-201007-10), 2021 National Innovation and Entrepreneurship Training Program for College Students (A3-0200-21-309010-315) and Open Project Funding from the Department of Science and Technology (E4-6100-21-201048). This work has also been supported by the National Natural Science Foundation of China (31970599) and the clinical discipline project of Shanghai Pudong (PWYgy2018-03 and PWZzk2017-31)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025